Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery (Apium graveolens):: correlating IgE reactivity with three-dimensional structure

被引:104
作者
Neudecker, P
Lehmann, K
Nerkamp, J
Haase, T
Wangorsch, A
Fötisch, K
Hoffmann, S
Rösch, P
Vieths, S
Scheurer, S
机构
[1] Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany
[2] Paul Ehrlich Inst, Dept Allergol, D-63225 Langen, Germany
关键词
allergen structure; allergy; cross-reactivity; hypoallergenic mutants; IgE-epitope analysis;
D O I
10.1042/BJ20031057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Birch pollinosis is often accompanied by adverse reactions to food due to pollen-allergen specific IgE cross-reacting with homologous food allergens. The tertiary structure of Pru av 1, the major cherry (Prunus avium) allergen, for example, is nearly identical with Bet v 1, the major birch (Betula verrucosa) pollen allergen. In order to define cross-reactive IgE epitopes, we generated and analysed mutants of Pru av 1 and Api g 1.0101, the major celery (Apium graveolens) allergen, by immunoblotting, EAST (enzyme allergosorbent test), CD and NMR spectroscopy. The mutation of Glu(45) to Trp(45) in the P-loop region, a known IgE epitope of Bet v 1, significantly reduced IgE binding to Pru av I in a subgroup of cherry-allergic patients. The backbone conformation of Pru av 1 wild-type is conserved in the three-dimensional structure of Pru av 1 Trp(45), demonstrating that the side chain of Glu(45) is involved in a cross-reactive IgE epitope. Accordingly, for a subgroup of celery-allergic patients, IgE binding to the homologous celery allergen Api g 1.0101 was enhanced by the mutation of Lys(44) to Glu. The almost complete loss of IgE reactivity to the Pru av 1 Pro(112) mutant is due to disruption of its tertiary structure. Neither the mutation Ala(112) nor deletion of the C-terminal residues 155-159 influenced IgE binding to Pru av 1. In conclusion, the structure of the P-loop partially explains the cross-reactivity pattern, and modulation of IgE-binding by site-directed mutagenesis is a promising approach to develop hypo-allergenic variants for patient-tailored specific immunotherapy.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 48 条